机译:碳-13和碳-14标记的Dabigatran eDilexilate和氚标记的Dabigatran
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
DMPKBoehringer Ingelheim Pharma GmbH &
Co. KGBirkendorfer Strasse 65 D‐88397 Biberach Germany;
DMPKBoehringer Ingelheim Pharma GmbH &
Co. KGBirkendorfer Strasse 65 D‐88397 Biberach Germany;
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
Chemical DevelopmentBoehringer Ingelheim Pharmaceuticals Inc.900 Ridgebury Road P.O. Box?368;
dabigatran etexilate; pradaxa; dabigatran; anticoagulant; carbon‐13; carbon‐14; tritium;
机译:碳-13和碳-14标记的Dabigatran eDilexilate和氚标记的Dabigatran
机译:DIVERSITY研究的设计和依据:达比加群酯对小儿静脉血栓栓塞的开放性随机研究
机译:使用电子医疗数据库评估药物潜在的潜在挑战的方法论挑战 - 以欧洲达比亚特兰替代品为例
机译:用碳-14,氘和氚标记的S'-羟基-L-色氨酸的合成
机译:在小龙虾或圆锥形虾中掺入碳14标记的N-乙酰葡萄糖胺和T标记的葡萄糖过程中甲壳素中间池的定量测定。
机译:DIVERSITY研究的设计和原理:达比加群酯对儿科静脉血栓栓塞的开放性随机研究
机译:根据欧洲标签在心房颤动中的脑卒中预防欧洲标签的P4600PRESENSEXILILATE:来自Gloria-AF登记处的调查结果